Possible Association of Intestinal Helminths and Protozoa With Colorectal Cancer Pathogenesis
Intestinal Helminths and Protozoan Infections in Patients With Colorectal Cancer: Prevalence and Possible Association With Cancer Pathogenesis
1 other identifier
observational
500
0 countries
N/A
Brief Summary
Colorectal cancer (CRC) has the third highest cancer incidence in the world. There is mounting evidence that the intestinal microbiota plays an important role in colorectal carcinogenesis. but there is no information on protozoa of intestinal microbiota except Blastocystis hominis, although data on this issue is scarce. In this study we are going to evaluate the prevalence of intestinal helminthes and protozoa in CRC patients and control group that includes random residents. Patients will be examined before, after surgery and chemotherapy. Parasites and protozoan infection intensity will be estimated by triple coproscopy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2015
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2015
CompletedFirst Submitted
Initial submission to the registry
May 29, 2017
CompletedFirst Posted
Study publicly available on registry
June 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedMarch 3, 2023
March 1, 2023
11 years
May 29, 2017
March 1, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Prevalence of intestinal helminths in patients with colorectal cancer and association with cancerogenesis
In this study we expect to find intestinal helminths in patients with colorectal cancer and determine their role in the development of colorectal cancer
from 2015 to 2018 years
Prevalence of Lamblia intestinalis and Cryptosporidium parvum in patients with colorectal cancer and association with cancerogenesis
In this study we expect to find pathogenic protozoa in patients with colorectal cancer and determine their role in the development of colorectal cancer
from 2015 to 2018 years
Prevalence of intestinal protozoa (commensals) in patients with colorectal cancer and association with cancerogenesis
In this study we are going to determine their prevalence and role in the development of colorectal cancer
from 2015 to 2018 years
Study Arms (8)
Patients with colorectal cancer
Patients hospitalized with colorectal cancer at the Department of Coloproctology of Republican Oncology Research Center.
Population
The control group includes residents of Tashkent city without any complaints from gastrointestinal tract matched by gender and age to the patients with colorectal cancer.
Patients with CRC without metastases
Patients hospitalized with colorectal cancer at the Department of Coloproctology of Republican Oncology Research Center.
Patients with CRC with metastases
Patients hospitalized with colorectal cancer at the Department of Coloproctology of Republican Oncology Research Center.
Patients with CRC before operation
Patients hospitalized with colorectal cancer before operation at the Department of Coloproctology of Republican Oncology Research Center.
Patients with CRC after operation
Patients hospitalized with colorectal cancer after operation at the Department of Coloproctology of Republican Oncology Research Center.
Patients with CRC before chemotherapy
Patients hospitalized with colorectal cancer before operation and chemotherapy at the Department of Chemotherapy of Republican Oncology Research Center.
Patients with CRC after chemotherapy
Patients hospitalized with colorectal cancer after operation and chemotherapy at the Department of Chemotherapy of Republican Oncology Research Center.
Interventions
Three stool samples for parasitological examination will be taken from control subjects and CRC patients at 1-2 days interval.
Eligibility Criteria
All patients with colorectal cancer hospitalized in Department of Coloproctology at Research Center of Oncology. Diagnosis of colorectal cancer is based on the results of clinical examination, endoscopic, histological, X-ray and laboratory data according to International Classification proposed by the American Joint Committee on Cancer (AJCC) with application TNM for diagnosis. The control group will be a residents of Tashkent city without any complaints from gastrointestinal tract matched by gender and age to the patients with CRC.
You may qualify if:
- All patients with colorectal cancer before, after surgery and chemotherapy.
- For control group:
- Includes all individuals that doesn't have any complaints from gastrointestinal tract
You may not qualify if:
- Age before 18.
- Patients with other gastrointestinal disorders
- Patients with any chronic concomitant diseases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Toychiev A, Abdujapparov S, Imamov A, Navruzov B, Davis N, Badalova N, Osipova S. Intestinal helminths and protozoan infections in patients with colorectal cancer: prevalence and possible association with cancer pathogenesis. Parasitol Res. 2018 Dec;117(12):3715-3723. doi: 10.1007/s00436-018-6070-9. Epub 2018 Sep 15.
PMID: 30220046RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Months
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 29, 2017
First Posted
June 1, 2017
Study Start
January 1, 2015
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
March 3, 2023
Record last verified: 2023-03